Skip to main content
. Author manuscript; available in PMC: 2016 May 26.
Published in final edited form as: Hepatology. 2008 Oct;48(4):1167–1174. doi: 10.1002/hep.22446

Figure 5.

Figure 5

Figure 5

Figure 5

Figure 5

a. Receiver Operating Characteristics for Ceruloplasmin Measured by Nephelometry and by Oxidase Methods in 140 patients with ALF. The area under the curve is 0.60 and 0.70, respectively.

b. Receiver Operating Characteristics for Ceruloplasmin Measured by Nephelometry and by Oxidase in 17 chronic Wilson Disease patients. The area under the curve is 0.87 and 0.89, respectively.

c. Receiver Operating Characteristics for Alkaline Phosphatase to Total Bilirubin Ratio and Hemoglobin (g/dL) and the diagnosis of Wilson Disease in ALF (ALF-WD). The area under the curve is 0.98 and 0.94, respectively.

d. Receiver Operating Characteristics for AST to ALT Ratio and Serum Copper (μg/dL) and the diagnosis of Wilson Disease in ALF. The area under the curve is 0.98 and 0.95, respectively.